|
Market Cap (20-Jun) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
MDC released this announcement to the ASX on 5 July 2021, 9:45. The announcement is marked as price sensitive, and is 3 page(s) in length and 215.8kb in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
At the date of this announcement, MDC was 0.018% short sold according to ASIC data. It was ranked the 583rd most shorted stock on the ASX. It is now ranked as the 544th most shorted stock on the ASX with 0.017% of total shares short sold as of the latest reported data (31 August 2021).
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| Medlab NRGBiotic Depression Study Results | 5 July 2021, 9:45 |
| Notification regarding unquoted securities - MDC | 29 June 2021, 15:40 |
| Proposed issue of securities - MDC | 28 June 2021, 16:03 |
| European and Canadian Patent Offices Grant NanoCelle Patents | 23 June 2021, 8:50 |
You must be logged in to post a reply.
Medlab Clinical 